Completed PHASE4 INTERVENTIONAL NCT00137579

Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation Therapy

Phase IV, Simple Blind, 2-Parallel Groups Randomized Trial to Evaluate the Safety and Effectiveness of the Intramuscular Vs Subcutaneous Route for the Administration of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation

Sponsor: Catalan Institute of Health

Conditions Influenza

Interventions Influenza vaccine intramuscular administration route

Updated 5 times since 2017 Last updated: Dec 12, 2005 Started: Sep 30, 2003 Completion: May 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00137579, this PHASE4 trial focuses on Influenza and remains completed. Sponsored by Catalan Institute of Health, it has been updated 5 times since 2003, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Catalan Institute of Health

Data source: Catalan Institute of Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain